Skip to main content
. Author manuscript; available in PMC: 2013 Mar 17.
Published in final edited form as: J Clin Psychopharmacol. 2009 Oct;29(5):478–483. doi: 10.1097/JCP.0b013e3181b2abf2

Table 4.

Number (%) of adverse events rated as possible, probable, or definite

Body System/SE Black Cohosh (n=15) Placebo (n=13)
Body as a whole
Irritability (0.0) 1 (7.7)
Listlessness (0.0) 1 (7.7)
Flu Symptoms (0.0) 1 (7.7)
Breast Tenderness (0.0) 1 (7.7)
Light Headedness 2 (15.4) 0 (0.0)
Dry Mouth 1 (7.7) 0 (0.0)
Diaphoresis 1 (7.7) 0 (0.0)
Pain 1 (7.7) 0 (0.0)
Edema 1 (7.7) 0 (0.0)
Gastrointestinal System
Bloated 1 (7.7) 0 (0.0)
Diarrhea 1 (7.7) 0 (0.0)
Constipated 0 (0.0) 1 (7.7)
Cramping 1 (7.7) 0 (0.0)
Urogenital System
Menstrual Flow 0 (0.0) 2 (15.4)
Spotting 0 (0.0) 1 (7.7)
Vaginal Bleeding 1 (7.7) 0 (0.0)
Nervous System
Difficulty falling asleep 2 (15.4) 0 (0.0)
Middle night awakening 1 (7.7) 0 (0.0)
Increased Anxiety 1 (7.7) 0 (0.0)